CTP Synthase 1 Is a Novel Therapeutic Target in Lymphoma

CTP Synthase 1 Is a Novel Therapeutic Target in Lymphoma

Lymphoma is the most common hematological malignancy and is among the 10 most prevalent cancers worldwide. Although survival has been improved by modern immunochemotherapeutic regimens, there remains a significant need for novel targeted agents to treat both B-cell and T-cell malignancies. Cytidine...

Full description

Bibliographic Details
Main Authors: Hélène Asnagli, Norbert Minet, Christina Pfeiffer, Eef Hoeben, Rebecca Lane, David Laughton, Louise Birch, Geraint Jones, Andrew Novak, Andrew E. Parker, Heinz Ludwig, Alain Fischer, Sylvain Latour, Philip A. Beer
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/HS9.0000000000000864

Internet

http://journals.lww.com/10.1097/HS9.0000000000000864

Similar Items